It is not surprising that healthcare professionals (HCP)s today are more digitally savvy than ever. The wave of consumerism led by digital natives has impacted HCPs when it comes to engaging with content on various digital channels for personal consumption. And the catalytic effect of the pandemic on the digital shift cannot be undermined. All this presents the newest challenge for the life sciences industry, requiring a complete revamp of the content strategy and channels for each specialty.

A report on the digital habits of HCPs across major regions provides some answers to pharma marketers looking to boost their post-pandemic physician engagement campaigns.

Over the years we have witnessed interesting changes in HCP behaviour and its impact on their digital choices. The pandemic, of course, accelerated digital adoption across the board. This study provides an understanding of the nuances of this big leap in digital preference by physicians and its far-reaching implications on pharma-physician engagement henceforth. The mix of channels, the time preference, and most importantly, hyper-customization of content at scale, will have a significant bearing on the success of any multichannel initiative. Regional and specialty level variations add another layer of complexity that pharma needs to address.

Among the findings of the study:

- 68% of HCPs indicated webinars or webcasts as their most preferred channel to receive information. While webinars have emerged as the most preferred channel for HCPs to engage with the pharma companies globally, HCPs in Europe prefer online journals (69%) over webinars (65%).

- Only 47% of HCPs prefer receiving communication through the marketing e-mail channel. At the same time, marketing emails are among the top 5 channels pharma companies use to engage HCPs.

- 50% of HCPs preferred to receive promotional content on their mobile or tablet, while 62% of HCPs and 57% of HCPs preferred to receive clinical and medical content on computer/laptops, respectively.

The survey findings also highlight the regional variation in HCPs’ device preferences and preferred time for receiving content.

- HCPs in Europe prefer to receive clinical, medical, and promotional content on their computers or laptops

- HCPs from Asia Pac prefer mobile devices and tablets.

- The preferred time for engagement for HCPs from Germany, Spain, and Italy is 5pm to 8pm on weekdays whereas it is 11am to 2pm for HCPs in the UK and post 8pm for HCPs in France.

- 77% of HCPs use digital channels primarily for personal learning and development.

- Across regions and specialties, clinical information and medical information continued to be the most sought-after content categories by HCPs irrespective of the changes in their channel, device and time preferences.

- HCPs have begun to prefer online journals over self-directed web detailing and MSLs. This reflects their increased expectations from pharma companies to share informative and educational content which they can access at their convenience and also use the content for their L&D priorities.

 

A copy of the survey can be accessed here.

 

 

 

 

 

 

Inspiration/Source/References

RECENT POSTS

The Transformational Impact of Artificial Intelligence on the Patient-Physician Relationship

In today’s ever-evolving healthcare landscape, the integration of artificial intelligence (AI) has ushered in a new era of possibilities, presenting…

What is Medical Communications? The definitive guide.

Medical Communications. The demand for clear and integrated dissemination of scientific knowledge is critical for the Pharmaceutical industry. Medical communications—or…

Enhancing engagement with healthcare professionals (HCPs): How AI is transforming Pharma relationships.

Pharmaceutical companies are progressively turning to the use of Artificial Intelligence (AI) as a tool to transform several aspects of…

Six communication trends Pharma needs to watch in 2024.

As we approach 2024, the Pharma industry’s focus on developing and maintaining meaningful relationships with healthcare professionals (HCPs) will only…

The EU Artificial Intelligence Act: A New Era of Regulation 
The EU's proposed AI Act, the world's first comprehensive legal framework for AI, is set to revolutionize global AI regulation. Learn about its risk classification levels and the potential implications for the Life Sciences industry.
0 +

YEARS IN

MARKET

0 +

THERAPY

AREAS

WORK IN

0 +

COUNTRIES


GET IN TOUCH

Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 16-year experience and expertise over 40 therapeutic areas.

SDM also offers strategic consulting services and can help with communication and engagement of your target audiences as part of market development opportunities.

Discover why over 95% of clients are “Extremely Satisfied” with SDM and over 90% say the agency deliver “Much more than expected”.